Patient-derived tumor xenograft

Dec 07, 2017

Curadev Announces Research Partnership With University of Texas Southwestern Medical Center, Dallas, TX, USA

Sep 18, 2017

Champions Oncology announces publication highlighting clinical correlation between patient-derived xenograft (PDX) model responses and patient responses to oncology therapies

Sep 14, 2017

Patient Derived Xenograft/PDX Models Market Worth 167.6 Million USD by 2022

Aug 30, 2017

St. Jude unveils powerful resource to advance treatment of pediatric solid tumors

Aug 21, 2017

Champions Oncology Announces Strategic Collaboration with AstraZeneca to Develop Unique Cohorts of Patient-Derived Xenograft (PDX) Models

Aug 18, 2017

Champions Oncology Announces Research Collaboration with The Addario Lung Cancer Medical Institute to Develop Unique Cohort of Patient-Derived Xenograft (PDX) Models

Jun 20, 2017

Oncology Based In-vivo CRO Market Size Worth $1.5 Billion by 2025: Grand View Research, Inc.